article thumbnail

2022 spells change for EU pharmaceutical legislation

European Pharmaceutical Review

It is too early to say because we have not seen the whole package of measures yet. THE EUROPEAN PARLIAMENT AND THE COUNCIL OF THE EUROPEAN UNION; 2004. One of the key priorities of the EU’s strategy is to encourage innovation to solve unmet medical needs. THE EUROPEAN PARLIAMENT AND THE COUNCIL OF THE EUROPEAN UNION; 2006.

article thumbnail

Medicare Part D for LTC Pharmacy: A Refresher

Integra X Files

Industry representatives spent many hours during 2004 discussing the needs of nursing home residents and the current standards of service.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Top 20 RNAi Therapeutic Companies Based on 2022 R&D Expenditure

PharmaShots

R&D Expenditure: $7.19B Founded Year: 2004 Total Employees: ~91,573,440 Headquarters: Paris, France Market Cap: $143.9B In Nov 2021, GSK entered into a license agreement with Arrowhead to develop and commercialize Arrowhead’s RNAi therapy, ARO-HSD. R&D Expenditure: $14.6B

article thumbnail

Five potential EU regulatory changes impacting the life sciences industry in 2023

European Pharmaceutical Review

Launch of the EU pharmaceutical package The European Commission plans to commence initiatives relating to the European Pharmaceutical Strategy (strategy) with the publication of the revised EU pharmaceutical package scheduled during the first quarter of 2023.

article thumbnail

Russia’s focus on domestic pharma production could shield it from sanctions’ effects

Pharmaceutical Technology

US President Joe Biden has gained approval from Congress for a new package of aid worth $40bn, and the US government announced last month that it plans to provide an additional $1bn in security assistance to Ukraine. Roszdravnadzor was founded by Vladimir Putin in 2004.

Vaccines 122
article thumbnail

Hashimoto’s and Graves’ Remission after Helicobacter Pylori Eradication

The Thyroid Pharmacist

Source: Bertalot et al, 2004). Source: Bertalot et al, 2004). MegaGuard and PyloGuard provide doses on the package. Reduction in TPO antibodies ranged from 50 to 99 percent, while reduction of TG antibodies ranged from 31 to 95 percent over the course of 17 to 22 months. (23). The five patients with Hashimoto’s and untreated H.

article thumbnail

Sleep Solutions for Hashimoto’s

The Thyroid Pharmacist

Be sure to follow the package directions and your practitioner’s guidance to determine the right dosage for you. Rosalind Press; 2004. [42] 42] Castiglioni C, Verrigni D, Okuma C, et al. Pyruvate dehydrogenase deficiency presenting as isolated paroxysmal exercise induced dystonia successfully reversed with thiamine supplementation.